Bart Barlogie

Bart Barlogie

UNVERIFIED PROFILE

Are you Bart Barlogie?   Register this Author

Register author
Bart Barlogie

Bart Barlogie

Publications by authors named "Bart Barlogie"

Are you Bart Barlogie?   Register this Author

100Publications

3194Reads

5Profile Views

Imipridone ONC201: combination therapy in hematologic malignancies.

Cell Cycle 2018 11;17(16):1947-1948. Epub 2018 Sep 11.

a Icahn School of Medicine , The Mount Sinai Medical Center , New York , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384101.2018.1490861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224273PMC
September 2019

Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma.

Mod Pathol 2019 Aug 2. Epub 2019 Aug 2.

Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0333-6DOI Listing
August 2019

PET-Computed Tomography in Myeloma: Current Overview and Future Directions.

PET Clin 2019 Jul;14(3):411-418

Mount Sinai Hospital/Tisch Cancer Institute, 1 Gustave L Levy Place, Box 1185, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2019.03.010DOI Listing
July 2019

Daratumumab-induced transient myopic shift.

Am J Ophthalmol Case Rep 2019 Mar 18;13:116-118. Epub 2018 Dec 18.

Department of Ophthalmology, Mount Sinai Medical Center, 1468 Madison Ave, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24519936183017
Publisher Site
http://dx.doi.org/10.1016/j.ajoc.2018.12.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312830PMC
March 2019

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.

Clin Cancer Res 2019 01 2;25(1):201-209. Epub 2018 Oct 2.

Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320275PMC
January 2019

Walking on myeloma.

Blood 2018 10;132(16):1724

Icahn School of Medicine at Mount Sinai.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-07
Publisher Site
http://dx.doi.org/10.1182/blood-2018-07-861096DOI Listing
October 2018

Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.

J Glob Oncol 2018 09 9;4:1-8. Epub 2017 May 9.

Shebli Atrash, Qing Zhang, Xenofon Papanikolaou, Caleb Stein, Al-Ola Abdallah, and Bart Barlogie, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and Qing Zhang, Levine Cancer Institute, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2016.008003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180798PMC
September 2018

The effect of novel therapies in high-molecular-risk multiple myeloma.

Clin Adv Hematol Oncol 2017 Nov;15(11):870-879

Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993678PMC
November 2017

Drug Combinations with Transplantation for Myeloma.

N Engl J Med 2017 07;377(1):91-2

University of Iowa Hospitals and Clinics, Iowa City, IA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1705671DOI Listing
July 2017

Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?

Immunotherapy 2016 17;8(3):367-84. Epub 2016 Feb 17.

Myeloma Institute, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.118DOI Listing
December 2016

CA-125 secreting IgG kappa multiple myeloma.

Am J Hematol 2016 Oct 14;91(10):E457-8. Epub 2016 Jul 14.

University of Arkansas for Medical Sciences, Myeloma Institute, Little Rock, Arkansas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24456DOI Listing
October 2016

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

Br J Haematol 2016 09 16;174(6):991-3. Epub 2015 Nov 16.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13830DOI Listing
September 2016

Muscular Relapse in a Patient With Multiple Myeloma.

J Clin Oncol 2015 Dec 28;33(34):e125-9. Epub 2014 Apr 28.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.6450DOI Listing
December 2015

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.

Genes Chromosomes Cancer 2015 Nov 29;54(11):692-701. Epub 2015 Jul 29.

Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644988PMC
November 2015

Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.

BMC Cancer 2015 Nov 6;15:864. Epub 2015 Nov 6.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1892-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636897PMC
November 2015

Using a latent class model to refine risk stratification in multiple myeloma.

Stat Med 2015 Sep 17;34(21):2971-80. Epub 2015 Jun 17.

Cancer Research And Biostatistics (CRAB), Seattle, WA, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.6557DOI Listing
September 2015

Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols.

Clin Case Rep 2015 Mar 13;3(3):183-92. Epub 2015 Feb 13.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences 4301 West Markham Slot 816, Little Rock, Arkansas, 72205.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccr3.180
Publisher Site
http://dx.doi.org/10.1002/ccr3.180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377252PMC
March 2015

Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance.

Ann Hepatol 2014 Jul-Aug;13(4):461-5

Division of Gastroenterology and Hepatology, Department of Medicine, Myeloma Institute for Research and Therapy. University of Arkansas For Medical Science, Little Rock, AR, U.S.A.

View Article

Download full-text PDF

Source
February 2015

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

J Clin Oncol 2015 Feb 20;33(6):657-64. Epub 2015 Jan 20.

Meletios A. Dimopoulos and Evangelos Terpos, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; Jens Hillengass and Hartmut Goldschmidt, University Hospital Heidelberg, Heidelberg, Germany; Saad Usmani, Carolinas Healthcare System, Charlotte, NC; Elena Zamagni and Michele Cavo, Bologna University School of Medicine, Bologna; Antonio Palumbo, S. Giovanni Battista Hospital, University of Turin, Turin, Italy; Suzanne Lentzsch, Columbia University College of Physicians and Surgeons, New York, NY; Faith E. Davies, Institute of Cancer Research, Sutton, United Kingdom; Noopur Raje, Massachusetts General Hospital Cancer Center; Kenneth Anderson, Dana-Farber Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; Orhan Sezer, Memorial Sisli Hospital, Istanbul, Turkey; Sonja Zweegman, VU University Medical Center, Amsterdam; Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, the Netherlands; Jatin Shah, MD Anderson Cancer Center, Houston, TX; Ashraf Badros, University of Maryland Medical Center, Baltimore, MD; Kazuyuki Shimizu, Tokai Central Hospital, Kakamigahara, Japan; Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France; Chor-Sang Chim, Queen Mary Hospital, University of Hong Kong, Hong Kong, Special Administrative Region; Jian Hou, Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China; Juan José Lahuerta, Hospital Universitario 12 de Octubre, Madrid, Spain; Artur Jurczyszyn, University Hospital, Krakow, Poland; Heinz Ludwig, Wilhelminenspital, Vienna, Austria; Bart Barlogie, University of Arkansas for Medical Sciences, Little Rock, AR; G. David Roodman, Indiana University School of Medicine, Indianapolis, IN; S. Vincent Rajkumar, Mayo Clinic, Rochester, MN; and Brian G.M. Durie, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9961DOI Listing
February 2015

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat.

BMC Bioinformatics 2015 Feb 25;16:63. Epub 2015 Feb 25.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-015-0478-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355992PMC
February 2015

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.

J Immunother 2015 Jan;38(1):24-36

*Myeloma Institute for Research and Therapy §Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR †Center for Cell and Gene Therapy, The Methodist Hospital, Texas Children's Hospital, Houston, TX ‡Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore ∥Department of Pediatrics, Baylor College of Medicine, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352951PMC
January 2015

Curing myeloma at last: defining criteria and providing the evidence.

Blood 2014 Nov 7;124(20):3043-51. Epub 2014 Oct 7.

Cancer Research And Biostatistics, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-07-552059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231416PMC
November 2014

Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.

Clin Lymphoma Myeloma Leuk 2014 Aug 28;14(4):e127-9. Epub 2014 Feb 28.

Myeloma Institute of Research and Therapy, Little Rock, AR. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.02.008DOI Listing
August 2014

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.

Genes Chromosomes Cancer 2014 Jul 17;53(7):549-57. Epub 2014 Mar 17.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, AR, 72205.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016160PMC
July 2014

The future of autologous stem cell transplantation in myeloma.

Blood 2014 Jul 3;124(3):328-33. Epub 2014 Jun 3.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-03-561985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102706PMC
July 2014

Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.

Clin Lymphoma Myeloma Leuk 2014 Jun 16;14(3):211-4. Epub 2013 Nov 16.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.11.004DOI Listing
June 2014

A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis.

Amyloid 2014 Jun 11;21(2):134-5. Epub 2014 Feb 11.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences , Little Rock, AR , USA .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/13506129.2014.883373DOI Listing
June 2014

Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.

PLoS One 2013 16;8(9):e74191. Epub 2013 Sep 16.

Myeloma Institute for Research and Therapy, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0074191PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774816PMC
May 2014

Can autologous bone marrow transplantation improve systolic function in patients with multiple myeloma related cardiac amyloidosis?

Int J Cardiol 2014 Mar 10;172(1):265-6. Epub 2014 Jan 10.

Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2013.12.249DOI Listing
March 2014

Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: a case report and review of literature.

Clin Lymphoma Myeloma Leuk 2013 Aug 5;13(4):502-6. Epub 2013 Jun 5.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.03.002DOI Listing
August 2013

NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.

Exp Hematol 2013 Jun 19;41(6):547-557.e2. Epub 2013 Feb 19.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648259PMC
June 2013

Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.

Am J Hematol 2013 Jun 28;88(6):463-71. Epub 2013 Mar 28.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971999PMC
June 2013

Developing and validating continuous genomic signatures in randomized clinical trials for predictive medicine.

Clin Cancer Res 2012 Nov 27;18(21):6065-73. Epub 2012 Aug 27.

Department of Data Science, The Institute of Statistical Mathematics, Tachikawa, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744097PMC
November 2012

Cure models as a useful statistical tool for analyzing survival.

Clin Cancer Res 2012 Jul 6;18(14):3731-6. Epub 2012 Jun 6.

Fred Hutchinson Cancer Research Center, Seattle, WA 98117, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744099PMC
July 2012

Proteasome inhibitors and bone disease.

Semin Hematol 2012 Jul;49(3):243-8

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2012.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383607PMC
July 2012

Prediction of cytogenetic abnormalities with gene expression profiles.

Blood 2012 May 10;119(21):e148-50. Epub 2012 Apr 10.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-10-388702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367903PMC
May 2012

The surgical management of abdominal pain in the multiple myeloma patient.

Am J Surg 2012 Feb 23;203(2):127-31. Epub 2011 Jul 23.

Department of Surgery, The University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2011.02.012DOI Listing
February 2012

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.

Cancer 2012 Jan 30;118(2):549-57. Epub 2011 Jun 30.

Myeloma Institute for Research and Therapy, Division of Supportive Care, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26302DOI Listing
January 2012

Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.

Clin Infect Dis 2011 Oct 16;53(7):671-6. Epub 2011 Aug 16.

Department of Preventive Medicine and Myeloma Institute forResearch and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cir441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166349PMC
October 2011

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Int J Hematol 2011 Oct 15;94(4):321-333. Epub 2011 Oct 15.

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 776, Little Rock, AR, 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-011-0948-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433024PMC
October 2011

Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma.

Cancer Nurs 2011 May-Jun;34(3):219-27

College of Nursing, University of Arkansas for Medical Sciences, 4301 W Markham St, Slot 529, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NCC.0b013e3181f9904dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086027PMC
August 2011

Could CR mean cure?

Blood 2011 Jul;118(3):483

University of Arkansas for Medical Sciences, Cancer Research and Biostatistics.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-05-350322DOI Listing
July 2011